Organ-on-Chip Market Robust Expansion is expected with a CAGR of 34.7% from 2024-2031.
The Organ-on-Chip Market is valued at US$ 134.9 Mn in 2023, and it is expected to reach US$ 1,424.0 Mn by 2031, with a CAGR of 34.7% during the forecast period of 2024-2031.
(EMAILWIRE.COM, July 24, 2024 ) InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the Organ-on-Chip Market- By Application (Drug Discovery, Toxicity Testing, Other Applications), By Offering (Product, Services), By Organ Type (Liver-on-a-Chip, Kidney-on-a-Chip, Lung-on-a-Chip, Heart-on-a-Chip, Brain-on-a-Chip, Other Organ-on-Chip), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Cosmetic Industry), Region, Market Outlook And Industry Analysis 2031"
Download Free Demo Report: https://www.insightaceanalytic.com/request-sample/2560
Organs-on-a-chip (OOCs) are in vitro-grown microscopic tissues and organs that facilitate the modeling of human physiology and disease. The technology has been developed as a result of the convergence of advancements in semiconductor fabrication, tissue engineering, and human cell sourcing. Novel techniques that accelerate cell growth and maturation, efficient gene editing, simultaneous testing of multiple samples, and the creation of intricate 3D structures have led to remarkable advancements in the organ-on-a-chip (OOC) field. Primary cells and cells obtained directly from patients are also included in OOC technology. The utilization of human OOCs that are capable of predicting human physiological responses offers a compelling approach to precision medicine, disease modeling, and drug development.
List of Prominent Players in the Organ-on-Chip Market:
Emulate, Inc.
Mimetas B.V.
Kirkstall Ltd.
Numa BioSciences
AxoSim
BICO Group AB
CN Bio Innovations Ltd.
SynVivo, Inc.
BEOnchip
The Charles Stark Draper Laboratory, Inc.
TissUse GmbH
InSphero
Obatala Sciences
Hesperos, Inc.
Cherry Biotech
Market Dynamics:
Drivers:
Organ-on-chips (OoCs) can mimic the complex interactions between organs, allowing for a more comprehensive evaluation of potential drug side effects. This enables earlier detection of toxicity issues, saving time and resources during drug development. The growing pharmaceutical industry constantly seeks new and effective drugs. OoCs offer a faster and more efficient platform for drug screening compared to traditional methods. Personalized medicine requires understanding individual patient responses to drugs. OoC technology allows for the creation of patient-specific models to predict treatment efficacy. Ethical concerns and limitations of traditional animal models for drug testing are pushing the need for more human-relevant alternatives. OoCs offer a more accurate representation of human biology, potentially leading to more reliable drug development outcomes. Regulatory changes by some governments to reduce or eliminate animal testing further incentivize the adoption of OoCs.
Challenges:
Organ-on-chips (OoCs) are intricate microfluidic devices requiring advanced microfabrication techniques. This complexity increases development costs and limits large-scale production. The field lacks standardized protocols for OoC design, operation, and data analysis. This inconsistency makes it difficult to compare results across different OoC platforms. Developing and manufacturing OoCs can be expensive, limiting accessibility for smaller research labs and startups. Bringing down production costs is essential for wider adoption.
Regional Trends:
The Asia Pacific region benefits from a robust network of leading academic and research institutions that promote innovation and foster collaboration, particularly in biotechnology fields such as organ-on-chip technology. This collaborative environment accelerates advancements in medical research and technology development. Moreover, the region boasts cost-effective manufacturing capabilities for high-tech devices, positioning it as an attractive hub for the production of organ-on-chip systems. The Asia Pacific region benefits from a robust network of leading academic and research institutions that promote innovation and foster collaboration, particularly in biotechnology fields such as organ-on-chip technology. This collaborative environment accelerates advancements in medical research and technology development. Moreover, the region boasts cost-effective manufacturing capabilities for high-tech devices, positioning it as an attractive hub for the production of organ-on-chip systems.
Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/2560
Recent Developments:
In March 2024, InSphero's liver disease team pushed the limits of in vitro models in MASH Drug Discovery with the publication of ground-breaking, peer-reviewed research in Nature's Scientific Reports.
In April 2024, CN Bio Innovations Ltd. gathered $21 million at the Series B investment round's first close.
Segmentation of Organ-on-Chip Market.
Global Organ-on-Chip Market, By Application
Drug Discovery
Toxicity Testing
Other Applications
Global Organ-on-Chip Market By Offering
Product
Services
Global Organ-on-Chip Market By Organ Type
Liver-on-a-Chip
Kidney-on-a-Chip
Lung-on-a-Chip
Heart-on-a-Chip
Brain-on-a-Chip
Other Organ-on-Chip
Global Organ-on-Chip Market By End User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Cosmetic Industry
Others
Global Organ-on-Chip Market By Region
North America-
The US
Canada
Mexico
Europe-
Germany
The UK
France
Italy
Spain
Rest of Europe
Asia-Pacific-
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific
Latin America-
Brazil
Argentina
Rest of Latin America
Middle East & Africa-
GCC Countries
South Africa
Rest of the Middle East and Africa
For More Customization @ https://www.insightaceanalytic.com/customisation/2560
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Download Free Demo Report: https://www.insightaceanalytic.com/request-sample/2560
Organs-on-a-chip (OOCs) are in vitro-grown microscopic tissues and organs that facilitate the modeling of human physiology and disease. The technology has been developed as a result of the convergence of advancements in semiconductor fabrication, tissue engineering, and human cell sourcing. Novel techniques that accelerate cell growth and maturation, efficient gene editing, simultaneous testing of multiple samples, and the creation of intricate 3D structures have led to remarkable advancements in the organ-on-a-chip (OOC) field. Primary cells and cells obtained directly from patients are also included in OOC technology. The utilization of human OOCs that are capable of predicting human physiological responses offers a compelling approach to precision medicine, disease modeling, and drug development.
List of Prominent Players in the Organ-on-Chip Market:
Emulate, Inc.
Mimetas B.V.
Kirkstall Ltd.
Numa BioSciences
AxoSim
BICO Group AB
CN Bio Innovations Ltd.
SynVivo, Inc.
BEOnchip
The Charles Stark Draper Laboratory, Inc.
TissUse GmbH
InSphero
Obatala Sciences
Hesperos, Inc.
Cherry Biotech
Market Dynamics:
Drivers:
Organ-on-chips (OoCs) can mimic the complex interactions between organs, allowing for a more comprehensive evaluation of potential drug side effects. This enables earlier detection of toxicity issues, saving time and resources during drug development. The growing pharmaceutical industry constantly seeks new and effective drugs. OoCs offer a faster and more efficient platform for drug screening compared to traditional methods. Personalized medicine requires understanding individual patient responses to drugs. OoC technology allows for the creation of patient-specific models to predict treatment efficacy. Ethical concerns and limitations of traditional animal models for drug testing are pushing the need for more human-relevant alternatives. OoCs offer a more accurate representation of human biology, potentially leading to more reliable drug development outcomes. Regulatory changes by some governments to reduce or eliminate animal testing further incentivize the adoption of OoCs.
Challenges:
Organ-on-chips (OoCs) are intricate microfluidic devices requiring advanced microfabrication techniques. This complexity increases development costs and limits large-scale production. The field lacks standardized protocols for OoC design, operation, and data analysis. This inconsistency makes it difficult to compare results across different OoC platforms. Developing and manufacturing OoCs can be expensive, limiting accessibility for smaller research labs and startups. Bringing down production costs is essential for wider adoption.
Regional Trends:
The Asia Pacific region benefits from a robust network of leading academic and research institutions that promote innovation and foster collaboration, particularly in biotechnology fields such as organ-on-chip technology. This collaborative environment accelerates advancements in medical research and technology development. Moreover, the region boasts cost-effective manufacturing capabilities for high-tech devices, positioning it as an attractive hub for the production of organ-on-chip systems. The Asia Pacific region benefits from a robust network of leading academic and research institutions that promote innovation and foster collaboration, particularly in biotechnology fields such as organ-on-chip technology. This collaborative environment accelerates advancements in medical research and technology development. Moreover, the region boasts cost-effective manufacturing capabilities for high-tech devices, positioning it as an attractive hub for the production of organ-on-chip systems.
Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/2560
Recent Developments:
In March 2024, InSphero's liver disease team pushed the limits of in vitro models in MASH Drug Discovery with the publication of ground-breaking, peer-reviewed research in Nature's Scientific Reports.
In April 2024, CN Bio Innovations Ltd. gathered $21 million at the Series B investment round's first close.
Segmentation of Organ-on-Chip Market.
Global Organ-on-Chip Market, By Application
Drug Discovery
Toxicity Testing
Other Applications
Global Organ-on-Chip Market By Offering
Product
Services
Global Organ-on-Chip Market By Organ Type
Liver-on-a-Chip
Kidney-on-a-Chip
Lung-on-a-Chip
Heart-on-a-Chip
Brain-on-a-Chip
Other Organ-on-Chip
Global Organ-on-Chip Market By End User
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Cosmetic Industry
Others
Global Organ-on-Chip Market By Region
North America-
The US
Canada
Mexico
Europe-
Germany
The UK
France
Italy
Spain
Rest of Europe
Asia-Pacific-
China
Japan
India
South Korea
Southeast Asia
Rest of Asia Pacific
Latin America-
Brazil
Argentina
Rest of Latin America
Middle East & Africa-
GCC Countries
South Africa
Rest of the Middle East and Africa
For More Customization @ https://www.insightaceanalytic.com/customisation/2560
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact Information:
Insight Ace Analytics
Diana Dsouza
Tel: +8884144123
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Insight Ace Analytics
Diana Dsouza
Tel: +8884144123
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results